Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia

[1] Pui C-H(2004)Acute lymphoblastic leukemia New Engl J Med 350 1535-1548

[2] Relling MV(1996)Infant leukaemia biology, aetiology and treatment Leukemia 10 372-377

[3] Downing JR(2007)A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial Lancet 370 240-250

[4] Greaves M(1998)Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants Leukemia 12 1344-1348

[5] Pieters R(1986)Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83) Klinische Padiatrie 199 151-160

[6] Schrappe M(2004)Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment New Engl J Med 351 533-542

[7] De Lorenzo P(2010)Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia Blood 115 1018-1025

[8] Hann I(2006)Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance Cancer Cell 10 331-342

[9] De Rossi G(2014)Glucocorticoid sensitisation in mixed lineage leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101 Eur J Cancer 50 1665-1674

[10] Felice M(1977)Calcium dependence of glucocorticoid-induced lymphocytolysis Proc Natl Acad Sci USA 74 638-642

[1] Pui C-H(2004)Acute lymphoblastic leukemia New Engl J Med 350 1535-1548

[2] Relling MV(1996)Infant leukaemia biology, aetiology and treatment Leukemia 10 372-377

[3] Downing JR(2007)A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial Lancet 370 240-250

[4] Greaves M(1998)Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants Leukemia 12 1344-1348

[5] Pieters R(1986)Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83) Klinische Padiatrie 199 151-160

[6] Schrappe M(2004)Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment New Engl J Med 351 533-542

[7] De Lorenzo P(2010)Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia Blood 115 1018-1025

[8] Hann I(2006)Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance Cancer Cell 10 331-342

[9] De Rossi G(2014)Glucocorticoid sensitisation in mixed lineage leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101 Eur J Cancer 50 1665-1674

[10] Felice M(1977)Calcium dependence of glucocorticoid-induced lymphocytolysis Proc Natl Acad Sci USA 74 638-642